Anbio Biotechnology (NNNN) vs VolitionRX (VNRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Anbio Biotechnology is the larger company by market cap ($202.8 million vs $6.6 million), about 30.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NNNN | VNRX |
|---|---|---|
| Share price | $4.62 | $0.2194 |
| Market cap | $202.78M | $6.60M |
| 1-day change | -5.71% | -2.92% |
| YTD return | -84.64% | — |
| 1-year return | -85.09% | — |
| P/E ratio (TTM) | 30.80 | — |
| EPS (TTM) | $0.15 | $-3.80 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $44.73 | $10.40 |
| 52-week low | $4.55 | $0.217 |
| Distance from 52-week high | -89.67% | -97.89% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +6107.84% |
| Average volume | 146.84K | 8.47M |
| Shares outstanding | 43.89M | 30.06M |
| Employees | 27 | 57 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Anbio Biotechnology is about 30.7 times larger than VolitionRX by market value ($202.78M vs $6.60M).
About Anbio Biotechnology
NNNN stock →Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, and internationally. The company offers lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, SHA dry chemistry, chemiluminescence immunoassay, and real-time polymerase chain reaction solutions; and SARS-CoV-2 and SARS-CoV-2/Flu A/Flu B antigen rapid test kits.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 27 employees
About VolitionRX
VNRX stock →VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 57 employees
NNNN vs VNRX FAQ
Which is bigger, Anbio Biotechnology or VolitionRX?
Anbio Biotechnology (NNNN) is larger, with a market capitalization of $202.78M compared with $6.60M for VolitionRX (VNRX).
Are Anbio Biotechnology and VolitionRX in the same industry?
Yes. Both are classified in the Biotechnology: In Vitro & In Vivo Diagnostic Substances industry within the Health Care sector.